NCT06474182View on ClinicalTrials.gov

Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

September 30, 2027

Conditions

Multiple MyelomaTotal Knee Replacement

Interventions

PROCEDURE

Blood sampling

DRUG

Apixaban

Treatment by Apixaban

Trial Locations (1)

42055

RECRUITING

CHU de Saint-Etienne, Saint-Etienne

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT06474182 - Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma | Biotech Hunter | Biotech Hunter